A Study of MET233 in Combination With MET097 in Individuals With Obesity or Overweight With or Without Diabetes
Abroad (travel likely)RecruitingPHASE1, PHASE2
Conditions
Obesity and Obesity-related Medical Conditions
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Altasciences Clinical Los Angeles, Inc., Cypress, California, United States
Study leads
Pfizer CT.gov Call Center
Study Director
Pfizer